4
Changes in Ownership
FENNEC PHARMACEUTICALS INC. Filed Acc 0001926254-26-000020
Chief Executive Officer acquired 1,159 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Hackman Jeffrey S. · Chief Executive Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-10-31 | Grant or award : show line 1 in the form | +1,159 | 70,844 | D |
Loading xslF345X06/form4-11022026_091107.xml…